EUVIMEDEUVIMED entdecken
Open Access

BTK inhibitors potently impair platelet aggregation as a class effect independent of BTK specificity or dose in CLL and MCL

Kensuke Kojima, Shinichiro Watanabe, Akari Takeuchi, Naoka Kunisawa, Shohei Yoshida

Journal of Clinical and Experimental Hematopathology · 2025

DOI: 10.3960/jslrt.25028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2025. Verfasst von Kensuke Kojima und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan. Hauptthemen laut MEDLINE: Platelet Aggregation, Leukemia, Lymphocytic, Chronic, B-Cell, Protein Kinase Inhibitors, Agammaglobulinaemia Tyrosine Kinase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet AggregationLeukemia, Lymphocytic, Chronic, B-CellProtein Kinase InhibitorsAgammaglobulinaemia Tyrosine KinaseLymphoma, Mantle-CellProtein-Tyrosine KinasesHumansMaleFemaleAgedMiddle AgedPiperidinesAdenineAged, 80 and overPyrimidinesBenzamidesPyrazines

Stichwörter der Autor:innen

Bruton’s tyrosine kinase inhibitionaspirinchronic lymphocytic leukemiamantle cell lymphomaplatelet function

Substanzen

Protein Kinase InhibitorsAgammaglobulinaemia Tyrosine KinaseBTK protein, humanPiperidinesAdenineibrutinibacalabrutinibPyrimidinesProtein-Tyrosine KinasesBenzamides

Autor:innen und Institutionen

  • Department of Hematology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan.
  • Clinical Laboratory Department, Kochi Medical School Hospital, Nankoku, Kochi, Japan.

Zitieren

APA

Kojima, K., Watanabe, S., Takeuchi, A., Kunisawa, N., & Yoshida, S. (2025). BTK inhibitors potently impair platelet aggregation as a class effect independent of BTK specificity or dose in CLL and MCL. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.25028

Vancouver

Kojima K, Watanabe S, Takeuchi A, Kunisawa N, Yoshida S. BTK inhibitors potently impair platelet aggregation as a class effect independent of BTK specificity or dose in CLL and MCL. Journal of Clinical and Experimental Hematopathology. 2025. doi:10.3960/jslrt.25028

BibTeX
@article{Kojima2025,
  author = {Kojima, Kensuke and Watanabe, Shinichiro and Takeuchi, Akari and Kunisawa, Naoka and Yoshida, Shohei},
  title = {BTK inhibitors potently impair platelet aggregation as a class effect independent of BTK specificity or dose in CLL and MCL},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2025},
  doi = {10.3960/jslrt.25028}
}
Kostenlos starten →